Page 4 - Repligen Co News Today

Oregon Public Employees Retirement Fund reduced its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 0.9% in the second quarter, according to its most recent filing with the SEC. The fund owned 15,007 shares of the biotechnology company’s stock after selling 131 shares during the period. Oregon Public Employees Retirement Fund’s holdings […]

Teacher Retirement System of Texas cut its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 31.9% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,997 shares of the biotechnology company’s stock after selling 1,870 shares during the quarter. Teacher Retirement […]

Virtu Financial LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 16.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,574 shares of the biotechnology company’s stock after buying an additional 794 shares during the period. […]

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1 […]

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The average 1-year […]

Alyeska Investment Group L.P. acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 398,003 shares of the biotechnology company’s stock, valued at approximately $67,008,000. Alyeska Investment Group L.P. owned about […]

Stephens Investment Management Group LLC reduced its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% during the first quarter, Holdings Channel.com reports. The institutional investor owned 528,464 shares of the biotechnology company’s stock after selling 17,490 shares during the quarter. Repligen accounts for about 1.5% of Stephens Investment Management Group LLC’s investment portfolio, […]

Stephens Investment Management Group LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 3.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 528,464 shares of the biotechnology company’s stock after selling 17,490 shares […]

Cerity Partners LLC increased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 333.5% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,929 shares of the biotechnology company’s stock after buying an additional 6,100 shares during the period. Cerity Partners LLC’s holdings […]

Wellington Management Group LLP grew its stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 79.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,493,551 shares of the biotechnology company’s stock after buying an additional 662,807 shares during the quarter. Wellington Management […]